I-131 tositumomab

Follicular low-grade non-Hodgkin's lymphoma: Long-term outcome with or without tumor progression

(2010) Jens Ersbøll et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Use of Integrated SPECT/CT Imaging for Tumor Dosimetry in I-131 Radioimmunotherapy: A Pilot Patient Study

(2009) Yuni K. Dewaraja et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

131I-Tositumomab (Bexxar®) vs. 90Y-Ibritumomab (Zevalin®) Therapy of Low-Grade Refractory/Relapsed Non-Hodgkin Lymphoma

(2009) Andrei Iagaru et al.   MOLECULAR IMAGING AND BIOLOGY

Harnessing the Energy: Development of Radioimmunotherapy for Patients with Non-Hodgkin's Lymphoma

(2009) S. A. Gregory et al.   ONCOLOGIST

Rationale for Consolidation to Improve Progression-Free Survival in Patients with Non-Hodgkin's Lymphoma: A Review of the Evidence

(2009) F. Morschhauser et al.   ONCOLOGIST

Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study

(2008) G. Salles et al.   BLOOD

Radiation Therapy with Tositumomab (B1) Anti-CD20 Monoclonal Antibody Initiates Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase-Dependent Cell Death that Overcomes Resistance to Apoptosis

(2008) A. Ivanov et al.   CLINICAL CANCER RESEARCH

Phase III Trial of Consolidation Therapy With Yttrium-90–Ibritumomab Tiuxetan Compared With No Additional Therapy After First Remission in Advanced Follicular Lymphoma

(2008) Franck Morschhauser et al.   JOURNAL OF CLINICAL ONCOLOGY

Radioimmunotherapy-Based Conditioning Regimens for Stem Cell Transplantation

(2008) Michelle M. Zhang et al.   SEMINARS IN HEMATOLOGY